Dudediligence.

Crescent Biopharma, Inc

CBIONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Dec ’24$0.00Mar ’25$1.0MMar ’26$0.00Jun ’26
Net income, by quarter
−$9.8MSep ’24−$17.9MDec ’24−$15.1MMar ’25−$21.8MJun ’25−$24.6MSep ’25−$23.3MDec ’25−$23.3MMar ’26−$24.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.2M$75,000$10,000none on file$10.8M
Operating income−$63.4M−$47.4M−$39.3M−$40.0M−$152.6M
Net income−$63.4M−$46.7M−$36.9M−$37.9M$153,942
Operating cash flow−$57.5M−$46.5M−$34.9M−$31.1M−$71.5M
Free cash flow−$57.5M−$46.5M−$34.9M−$31.1M−$72.5M
Cash$90.3M$47.9M$41.8M$34.8M$213.2M
Shares outstanding52.3M54.4M64.4M1.0M27.6M